SEC Form 4 · accession 0002039294-26-000010
Century Therapeutics, Inc. · IPSC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Chad Cowan
Officer — Chief Scientific Officer
Period of report
Jun 11, 2026
Accepted (ET)
Jun 15, 2026 · 7:54 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001850119
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 11, 2026 | F | 358 | $2.24 | D | 1,175,322 | D | |
| Common StockF2 | holding | — | — | — | 10,697 | I | By Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units.
- F2Shares held by the Cowan Investment Nominee Trust. The Reporting Person disclaims beneficial ownership except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose.